Anavex Life Sciences Corporation (NASDAQ:AVXL) shares, rose in value on Thursday, March 27, with the stock price up by 1.92% to the previous day’s close as strong demand from buyers drove the stock to $9.54.
Actively observing the price movement in the last trading, the stock closed the session at $9.36, falling within a range of $9.24 and $9.86. The value of beta (5-year monthly) was 0.94. Referring to stock’s 52-week performance, its high was $14.44, and the low was $3.25. On the whole, AVXL has fluctuated by 18.22% over the past month.
With the market capitalization of Anavex Life Sciences Corporation currently standing at about $811.51 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-11.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AVXL’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of AVXL currently trading nearly 4.85% and 4.95% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.55, while the 7-day volatility ratio is showing 5.81% which for the 30-day chart, stands at 6.37%. Furthermore, Anavex Life Sciences Corporation (AVXL)’s beta value is 0.78, and its average true range (ATR) is 0.57.
A comparison of Anavex Life Sciences Corporation (AVXL) with its peers suggests the former has fared considerably weaker in the market. AVXL showed an intraday change of 1.92% in last session, and over the past year, it grew by 109.67%%.
Data on historical trading for Anavex Life Sciences Corporation (NASDAQ:AVXL) indicates that the trading volumes over the past 10 days have averaged 1.11 and over the past 3 months, they’ve averaged 1.40 million. According to company’s latest data on outstanding shares, there are 84.99 million shares outstanding.
Nearly 3.04% of Anavex Life Sciences Corporation’s shares belong to company insiders and institutional investors own 34.48% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 24.04 million shares as on 2025-03-14, resulting in a short ratio of 24.01. According to the data, the short interest in Anavex Life Sciences Corporation (AVXL) stood at 2915.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 24.2 million. The stock has fallen by -11.17% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AVXL stock heading into the next quarter.
